These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9128832)

  • 21. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.
    File SE; Gonzalez LE
    Pharmacol Biochem Behav; 1996 May; 54(1):123-8. PubMed ID: 8728549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine.
    Limón-Morales O; Soria-Fregozo C; Arteaga-Silva M; Vázquez-Palacios G; Bonilla-Jaime H
    Physiol Behav; 2014 Jan; 124():37-44. PubMed ID: 24211235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively.
    Andrews N; Hogg S; Gonzalez LE; File SE
    Eur J Pharmacol; 1994 Nov; 264(3):259-64. PubMed ID: 7698163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
    Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course of the effects of adrenalectomy and corticosterone replacement on 5-HT1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain: an autoradiographic analysis.
    Tejani-Butt SM; Labow DM
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):481-6. PubMed ID: 7862863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress-induced alterations of somatodendritic 5-HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus--in vitro electrophysiological evidence.
    Laaris N; Le Poul E; Hamon M; Lanfumey L
    Fundam Clin Pharmacol; 1997; 11(3):206-14. PubMed ID: 9243251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.
    Blier P; de Montigny C
    Synapse; 1987; 1(5):470-80. PubMed ID: 2905533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P; Serrano A; Scatton B
    Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo administration of the 5-HT1A receptor agonist 8-OH-DPAT interferes with brain GABA(A)/benzodiazepine receptor complexes.
    Söderpalm B; Andersson G; Enerbäck C; Engel JA
    Neuropharmacology; 1997 Aug; 36(8):1071-7. PubMed ID: 9294972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of autoshaping procedures on 3H-8-OH-DPAT-labeled 5-HT1a binding and 125I-LSD-labeled 5-HT2a binding in rat brain.
    Tomie A; Di Poce J; Aguado A; Janes A; Benjamin D; Pohorecky L
    Brain Res; 2003 Jun; 975(1-2):167-78. PubMed ID: 12763605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.
    Cox RF; Meller E; Waszczak BL
    Synapse; 1993 Aug; 14(4):297-304. PubMed ID: 8248853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
    Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
    Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
    Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
    J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of orally administered 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole (MKC-242) with 5-HT1A receptors in rat brain.
    Asano S; Matsuda T; Yoshikawa T; Somboonthum P; Tasaki H; Abe M; Baba A
    Jpn J Pharmacol; 1997 May; 74(1):69-75. PubMed ID: 9195299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.
    Sprouse JS; Aghajanian GK
    Neuropharmacology; 1988 Jul; 27(7):707-15. PubMed ID: 2901680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain.
    Tanaka H; Shimizu H; Kumasaka Y; Hirose A; Tatsuno T; Nakamura M
    Brain Res; 1991 Apr; 546(2):181-9. PubMed ID: 1648988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.